MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Movement Disorders Associated with Infectious Encephalitis in Pediatric Patients

    M. Mnif, H. Benrhouma, T. Benyounes, H. Klaa, Z. Miladi, A. Zioudi, I. Turki, I. Kraoua (Tunis, Tunisia)

    Objective: The objective of our study is to report the clinical and imaging profile of a cohort of pediatric patients with movement disorders (MDs) associated…
  • 2024 International Congress

    Oromandibular Dystonia in Hashimoto Encephalopathy: An Unusual Association Not To Miss

    S. Jha (Kolkata, India)

    Objective: To describe a case of proven Hashimoto Encephalopathy presenting with oromandibular dystonia (OMD) and orofacial dyskinesias (OFD) Background: Neurologic manifestations of Hashimoto’s Encephalopathy (HE)…
  • 2024 International Congress

    A comprehensive at-home and in-hospital work-up of patients with Parkinson’s disease receiving fosflevodopa/fosfcarbidopa continuous subcutaneous infusion

    G. Lazzeri, C. Baiata, F. Del Sorbo, M. Corradi, M. Barichella, L. Caffi, C. Palmisano, P. Soliveri, G. Pezzoli, IU. Isaias (Milan, Italy)

    Objective: Continuous infusion of fosflevodopa/foscarbidopa is a promising treatment for patients with Parkinson’s disease (PD) and severe motor fluctuations unresponsive to conventional therapy. Patient selection…
  • 2024 International Congress

    MRgFUS thalamotomy for essential tremor: Lesion location and clinical outcomes

    M. Rodriguez-Oroz, AA. Arcadi, LGQ. Gonzalez Quarante, IA. Aviles-Olmos, AMB. Bastidas, AJH. Jimenez Huete, AG. Gorospe, JG. Guridi (Pamplona, Spain)

    Objective: To examine the clinical outcomes and their relationship with patients’ baseline demographic and clinical features and lesion characteristics at 6-month follow-up in ET patients.…
  • 2024 International Congress

    Functional neurological disorders might be a frequent cause of slow orthostatic tremor: insights from a case series.

    A. Querejeta-Coma, L. Yupanqui-Guerra, A. Gómez-Domínguez, C. Ordas-Bandera (Móstoles, Spain)

    Objective: To study the clinical and electrophysiological characteristics of series of patients with slow orthostatic tremor (sOt) Background: sOT is characterized by tremor <13Hz affecting…
  • 2024 International Congress

    Improvement in upper limb spasticity patterns in the elderly following treatment with incobotulinumtoxinA: a pooled analysis

    M. Munin, A. Camões-Barbosa, C. Cordero-García, M. Althaus, G. Comes, M. Vacchelli, C. Walter, J. Wissel (Pittsburgh, USA)

    Objective: To compare changes from baseline in upper limb spasticity (ULS) severity in different spastic patterns at 4 weeks and 12 weeks post-injection of incobotulinumtoxinA…
  • 2024 International Congress

    Transcranial magnetic stimulation target comparison identifies motor network reorganization associated with behavioral improvement in writer’s cramp dystonia

    N. Bukhari-Parlakturk, P. Mulcahey, M. Lutz, R. Ghazi, Z. Huang, M. Dannhauer, P. Termsarasab, B. Scott, Z. Simsek, S. Groves, M. Lipp, M. Fei, T. Tran, E. Wood, L. Beynel, C. Petty, J. Voyvodic, L. Appelbaum, H. Al-Khalidi, S. Davis, A. Michael, A. Peterchev, N. Calakos (Durham, USA)

    Objective: This study aims to reveal the motor network effects of repetitive transcranial magnetic stimulation (rTMS) in Writer's cramp (WC) subjects that correspond to behavioral efficacy.…
  • 2024 International Congress

    Beyond the Surface: Electromyography in Cervical Dystonia

    S. Lagerweij, M. van Egmond, M. Smit, L. Centen, M. van Dijk, JW. Elting, M. Tijssen (Groningen, Netherlands)

    Objective: To evaluate the presence of co-contractions and overflow in cervical dystonia (CD) patients and appraise the applicability of intermuscular coherence as an objective biomarker…
  • 2024 International Congress

    Istradefylline therapy for dystonia in Parkinson’s disease

    NAO. Kanzato, KOH. Nakachi, SAT. Mochizuki, (Okinawa, Japan)

    Objective: To clarify the basal ganglia network links between PD and Dystonia in PD (Dys-PD) co-occur, and to get the conceptually novel pharmacotherapy. Background: Dys-PD is one…
  • 2024 International Congress

    Preclinical Studies: Investigating Serum-Based Exosomal miRNAs in Prodromal Drug-Induced Parkinson’s Disease

    M. Ahmad (Hyderabad, India)

    Objective: This work aims to elucidate the identification of homologs of miRNAs in a pronormal stage of Parkinson`s disease. Background: Parkinson's disease (PD) is defined…
  • « Previous Page
  • 1
  • …
  • 343
  • 344
  • 345
  • 346
  • 347
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley